Experienced in Lung Metastases

Perran F. Yumuk

Ihlas Marmara Evleri - I. Kisim, TR 
Experienced in Lung Metastases
Ihlas Marmara Evleri - I. Kisim, TR 
OverviewLocationsClinical Research

Overview

Perran Yumuk practices in Ihlas Marmara Evleri - I. Kisim, Turkey. Yumuk is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Breast Cancer, Pleural Effusion, and Gastrectomy.

Their clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lung Metastases.

Locations

Ihlas Marmara Evleri - I. Kisim, Turkey
Other Locations
Istanbul, 34450, Turkey
Golmarmara, Turkey
Kaynarca, 34890, Turkey
Pendik, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3

78 Total Publications

Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups.
Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups.
Journal: Future oncology (London, England)
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yumuk's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile